Adrenomedullin, an autocrine mediator of blood-brain barrier function

Hypertension Research

Volumn 26, Issue SUPPL., 2003, Pages

  Kis, Béla ^a,b   Ábrahám, Csongor S ^c   Deli, Mária A ^d   Kobayashi, Hideyuki ^e   Niwa, Masami ^f   Yamashita, Hiroshi ^b   Busija, David W ^a   Ueta, Yoichi ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^c N Gene Research Laboratories   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e UNIVERSITY OF MIYAZAKI   (Japan)

^f NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adrenomedullin; Blood brain barrier; Cerebral circulation; Endothelial cells

Indexed keywords

ADRENOMEDULLIN; CYCLIC AMP; ENDOTHELIN 1; ICOSANOID; NITRIC OXIDE;

ADRENAL MEDULLA; ANGIOGENESIS; ASTROCYTE; AUTOCRINE EFFECT; BLOOD BRAIN BARRIER; BRAIN BLOOD FLOW; BRAIN BLOOD VESSEL; BRAIN CIRCULATION; BRAIN ISCHEMIA; CELL DIFFERENTIATION; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; NONHUMAN; PARACRINE SIGNALING; PERIPHERAL CIRCULATION; PROTEIN SECRETION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

ADRENOMEDULLIN; ANIMALS; AUTOCRINE COMMUNICATION; BLOOD-BRAIN BARRIER; HUMANS; PEPTIDES;

EID: 0037300219     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.26.S61     Document Type: Review

References (127)

1. Kitamura K, Kangawa K, Kawamoto M, et al: Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun 1993; 192: 553-560.
2. Sakata J, Shimokubo T, Kitamura K, et al: Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide. Biochem Biophys Res Commun 1993; 195: 921-927.
3. Sugo S, Minamino N, Kangawa K, et al: Endothelial cells actively synthesize and secrete adrenomedullin. Biochem Biophys Res Commun 1994; 201: 1160-1166.
4. Joo F: Endothelial cells of the brain and other organ systems: some similarities and differences. Prog Neurobiol 1996; 48: 255-273.
5. Rubin LL, Staddon JM: The cell biology of the blood-brain barrier. Annu Rev Neurosci 1999; 22: 11-28.
6. Kis B, Kaiya H, Nishi R, et al: Cerebral endothelial cells are a major source of adrenomedullin. J Neuroendocrinol 2002; 14: 283-293.
7. Kis B, Deli MA, Kobayashi H, et al: Adrenomedullin regulates blood-brain barrier functions in vitro. Neuroreport 2001; 12: 4139-4142.
8. Yoshimoto S, Ishizaki Y, Kurihara H, et al: Cerebral microvessel endothelium is producing endothelin. Brain Res 1990; 508: 283-285.
9. Morin AM, Stanboli A: Nitric oxide synthase in cultured endothelial cells of cerebrovascular origin: cytochemistry. J Neurosci Res 1993; 36: 272-279.
10. Gimbrone MA Jr, Majeau GR, Atkinson WJ, Sadler W, Cruise SA: Angiotensin-converting enzyme activity in isolated brain microvessels. Life Sci 1979; 25: 1075-1083.
11. Kis B, Szabo CA, Pataricza J, et al: Vasoactive substances produced by cultured rat brain endothelial cells. Eur J Pharmacol 1999; 368: 35-42.
12. Moore SA, Spector AA, Hart MN: Eicosanoid metabolism in cerebromicrovascular endothelium. Am J Physiol 1988; 254: C37-44.
13. de Vries HE, Kuiper J, de Boer AG, van Berkel TJ, Breimer DD: Characterization of the scavenger receptor on bovine cerebral endothelial cells in vitro. J Neurochem 1993; 61: 1813-1821.
14. Butt AM, Jones HC: Effect of histamine and antagonists on electrical resistance across the blood-brain barrier in rat brain-surface microvessels. Brain Res 1992; 569: 100-105.
15. Schinkel AH: P-Glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 179-194.
16. Betz AL, Firth JA, Goldstein GW: Polarity of the blood-brain barrier: distribution of enzymes between the luminal and antiluminal membranes of brain capillary endothelial cells. Brain Res 1980; 192: 17-28.
17. Deli MA, Joo F: Cultured vascular endothelial cells of the brain. Keio J Med 1996; 45: 183-198.
18. Pardridge WM, Boado RJ, Farrell CR: Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier: studies with quantitative western blotting and in situ hybridization. J Biol Chem 1990; 265: 18035-18040.
19. Betz AL, Goldstein GW: Polarity of the blood-brain barrier: neutral amino acid transport into isolated brain capillaries. Science 1978; 202: 225-227.
20. Jefferies WA, Brandon MR, Hunt SV, Williams AF, Gatter KC, Mason DY: Transferrin receptor on endothelium of brain capillaries. Nature 1984; 312: 162-163.
21. Kusuhara H, Sugiyama Y: Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 2). Drug Discov Today 2001; 6: 206-212.
22. Kusuhara H, Sugiyama Y: Efflux transport systems for drugs at the blood-brain barrier and blood-cerebrospinal fluid barrier (Part 1). Drug Discov Today 2001; 6: 150-156.
23. +-dependent glutamate transporters (EAAT1, EAAT2, and EAAT3) of the blood-brain barrier: a mechanism for glutamate removal. J Biol Chem 1999; 274: 31891-31895.
24. Brust P, Friedrich A, Krizbai IA, et al: Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells. J Neurochem 2000; 74: 1241-1248.
25. Huszti Z, Deli MA, Joo F: Carrier-mediated uptake and release of histamine by cultured rat cerebral endothelial cells. Neurosci Lett 1995; 184: 185-188.
26. Janzer RC, Raff MC: Astrocytes induce blood-brain barrier properties in endothelial cells. Nature 1987; 325: 253-257.
27. Bauer HC, Bauer H: Neural induction of the blood-brain barrier: still an enigma. Cell Mol Neurobiol 2000; 20: 13-28.
28. Wolburg H, Neuhaus J, Kniesel U, et al: Modulation of tight junction structure in blood-brain barrier endothelial cells: effects of tissue culture, second messengers and cocultured astrocytes. J Cell Sci 1994; 107: 1347-1357.
29. Cecchelli R, Dehouck B, Descamps L, et al: In vitro model for evaluating drug transport across the blood-brain barrier. Adv Drug Deliv Rev 1999; 36: 165-178.
30. Rubin LL, Hall DE, Porter S, et al: A cell culture model of the blood-brain barrier. J Cell Biol 1991; 115: 1725-1735.
31. Schroeter ML, Muller S, Lindenau J, et al: Astrocytes induce manganese superoxide dismutase in brain capillary endothelial cells. Neuroreport 2001; 12: 2513-2517.
32. Shafer RA, Murphy S: Activated astrocytes induce nitric oxide synthase-2 in cerebral endothelium via tumor necrosis factor α. Glia 1997; 21: 370-379.
33. Risau W, Esser S, Engelhardt B: Differentiation of blood-brain barrier endothelial cells. Pathol Biol (Paris) 1998; 46: 171-175.
34. Mi H, Haeberle H, Barres BA: Induction of astrocyte differentiation by endothelial cells. J Neurosci 2001; 21: 1538-1547.
35. Isumi Y, Shoji H, Sugo S, et al: Regulation of adrenomedullin production in rat endothelial cells. Endocrinology 1998; 139: 838-846.
36. Ladoux A, Frelin C: Coordinated up-regulation by hypoxia of adrenomedullin and one of its putative receptors (RDC-1) in cells of the rat blood-brain barrier. J Biol Chem 2000; 275: 39914-39919.
37. Brown ML, Deykin D: Passage state affects arachidonic acid content and eicosanoid release in porcine aortic endothelial cells. Arterioscler Thromb 1991; 11: 167-173.
38. Goetz IE, Warren J, Estrada C, Roberts E, Krause DN: Long-term serial cultivation of arterial and capillary endothelium from adult bovine brain. In Vitro Cell Dev Biol 1985; 21: 172-180.
39. Shi F, Audus KL: Biochemical characteristics of primary and passaged cultures of primate brain microvessel endothelial cells. Neurochem Res 1994; 19: 427-433.
40. Minamino N, Kikumoto K, Isumi Y: Regulation of adrenomedullin expression and release. Microsc Res Tech 2002; 57: 28-39.
41. Isumi Y, Minamino N, Katafuchi T, et al: Adrenomedullin production in fibroblasts: its possible function as a growth regulator of Swiss 3T3 cells. Endocrinology 1998; 139: 2552-2563.
42. Takahashi K, Satoh F, Hara E, et al: Production and secretion of adrenomedullin from glial cell tumors and its effects on cAMP production. Peptides 1997; 18: 1117-1124.
43. Dehouck MP, Vigne P, Torpier G, Breittmayer JP, Cecchelli R, Frelin C: Endothelin-1 as a mediator of endothelial cell-pericyte interactions in bovine brain capillaries. J Cereb Blood Flow Metab 1997; 17: 464-469.
44. Serrano J, Uttenthal LO, Martinez A, et al: Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res 2000; 853: 245-268.
45. Serrano J, Alonso D, Encinas JM, et al: Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience 2002; 109: 717-731.
46. Sugo S, Minamino N, Shoji H, et al: Production and secretion of adrenomedullin from vascular smooth muscle cells: augmented production by tumor necrosis factor-α. Biochem Biophys Res Commun 1994; 203: 719-726.
47. Takahashi K, Nakayama M, Totsune K, et al: Increased secretion of adrenomedullin from cultured human astrocytes by cytokines. J Neurochem 2000; 74: 99-103.
48. Ueta Y, Kitamura K, Isse T, et al: Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci Lett 1995; 202: 37-40.
49. Takahashi K, Satoh F, Hara E, et al: Production and secretion of adrenomedullin by cultured choroid plexus carcinoma cells. J Neurochem 1997; 68: 726-731.
50. Washimine H, Asada Y, Kitamura K, et al: Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem Cell Biol 1995; 103: 251-254.
51. Nagata N, Kato J, Kitamura K, et al: Dissociation of adrenomedullin concentrations in plasma and cerebrospinal fluid in pregnant and non-pregnant women. Eur J Endocrinol 1998; 139: 611-614.
52. Fujioka M, Nishio K, Sakaki T, Minamino N, Kitamura K: Adrenomedullin in patients with cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2000; 31: 3079-3083.
53. Hwang IS, Tang F: Peripheral distribution and gene expression of adrenomedullin in the rat: possible source of blood adrenomedullin. Neuropeptides 2000; 34: 32-37.
54. Nishikimi T, Kitamura K, Saito Y, et al: Clinical studies on the sites of production and clearance of circulating adrenomedullin in human subjects. Hypertension 1994; 24: 600-604.
55. Nishikimi T, Matsuoka H, Shimada K, Matsuo H, Kangawa K: Production and clearance sites of two molecular forms of adrenomedullin in human plasma. Am J Hypertens 2000; 13: 1032-1034.
56. Hinson JP, Kapas S, Smith DM: Adrenomedullin, a multifunctional regulatory peptide. Endocr Rev 2000; 21: 138-167.
57. Kapas S, Catt KJ, Clark AJ: Cloning and expression of cDNA encoding a rat adrenomedullin receptor. J Biol Chem 1995; 270: 25344-25347.
58. McLatchie LM, Fraser NJ, Main MJ, et al: RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-339.
59. Hanze J, Dittrich K, Dotsch J, Rascher W: Molecular cloning of a novel human receptor gene with homology to the rat adrenomedullin receptor and high expression in heart and immune system. Biochem Biophys Res Commun 1997; 240: 183-188.
60. Kennedy SP, Sun D, Oleynek JJ, Hoth CF, Kong J, Hill RJ: Expression of the rat adrenomedullin receptor or a putative human adrenomedullin receptor does not correlate with adrenomedullin binding or functional response. Biochem Biophys Res Commun 1998; 244: 832-837.
61. Kobayashi H, Minami S, Yamamoto R, et al: Adrenomedullin receptors in rat cerebral microvessels. Brain Res Mol Brain Res 2000; 81: 1-6.
62. Oliver KR, Wainwright A, Edvinsson L, Pickard JD, Hill RG: Immunohistochemical localization of calcitonin receptor-like receptor and receptor activity-modifying proteins in the human cerebral vasculature. J Cereb Blood Flow Metab 2002; 22: 620-629.
63. Moreno MJ, Cohen Z, Stanimirovic DB, Hamel E: Functional calcitonin gene-related peptide type 1 and adrenomedullin receptors in human trigeminal ganglia, brain vessels, and cerebromicrovascular or astroglial cells in culture. J Cereb Blood Flow Metab 1999; 19: 1270-1278.
64. Yeung VT, Ho SK, Nicholls MG, Cockram CS: Adrenomedullin, a novel vasoactive hormone, binds to mouse astrocytes and stimulates cyclic AMP production. J Neurosci Res 1996; 46: 330-335.
65. Deli MA, Dehouck MP, Abraham CS, Cecchelli R, Joo F: Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3′,5′-monophosphate. Exp Physiol 1995; 80: 675-678.
66. Deli MA, Abraham CS, Takahata H, Niwa M: Tissue plasminogen activator inhibits P-glycoprotein activity in brain endothelial cells. Eur J Pharmacol 2001; 411: R3-R5.
67. Kastin AJ, Akerstrom V, Hackler L, Pan W: Adrenomedullin and the blood-brain barrier. Horm Metab Res 2001; 33: 19-25.
68. Michibata H, Mukoyama M, Tanaka I, et al: Autocrine/paracrine role of adrenomedullin in cultured endothelial and mesangial cells. Kidney Int 1998; 53: 979-985.
69. Michel CC, Curry FE: Microvascular permeability. Physiol Rev 1999; 79: 703-761.
70. Shindo T, Kurihara Y, Nishimatsu H, et al: Vascular abnormalities and elevated blood pressure in mice lacking adrenomedullin gene. Circulation 2001; 104: 1964-1971.
71. Caron KM, Smithies O: Extreme hydrops fetalis and cardiovascular abnormalities in mice lacking a functional adrenomedullin gene. Proc Natl Acad Sci U S A 2001; 98: 615-619.
72. Kis B, Abraham CS, Deli MA, et al: Adrenomedullin in the cerebral circulation. Peptides 2001; 22: 1825-1834.
73. Nakamura K, Toda H, Terasako K, et al: Vasodilative effect of adrenomedullin in isolated arteries of the dog. Jpn J Pharmacol 1995; 67: 259-262.
74. Baskaya MK, Suzuki Y, Anzai M, et al: Effects of adrenomedullin, calcitonin gene-related peptide, and amylin on cerebral circulation in dogs. J Cereb Blood Flow Metab 1995; 15: 827-834.
75. Wang X, Yue TL, Barone FC, et al: Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci U S A 1995; 92: 11480-11484.
76. Nishimura Y, Suzuki A: Relaxant effects of vasodilator peptides on isolated basilar arteries from stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 1997; 24: 157-161.
77. Sams A, Knyihar-Csillik E, Engberg J, et al: CGRP and adrenomedullin receptor populations in human cerebral arteries: in vitro pharmacological and molecular investigations in different artery sizes. Eur J Pharmacol 2000; 408: 183-193.
78. Lang MG, Paterno R, Faraci FM, Heistad DD: Mechanisms of adrenomedullin-induced dilatation of cerebral arterioles. Stroke 1997; 28: 181-185.
79. Mori Y, Takayasu M, Suzuki Y, Shibuya M, Yoshida J, Hidaka H: Effects of adrenomedullin on rat cerebral arterioles. Eur J Pharmacol 1997; 330: 195-198.
80. Dogan A, Suzuki Y, Koketsu N, et al: Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1997; 17: 19-25.
81. Takao M, Tomita M, Tanahashi N, Kobari M, Fukuuchi Y: Transient vasodilatory effects of adrenomedullin on cerebral parenchymal microvessels in cats. Neurosci Lett 1999; 268: 147-150.
82. Hirata Y, Hayakawa H, Suzuki Y, et al: Mechanisms of adrenomedullin-induced vasodilation in the rat kidney. Hypertension 1995; 25: 790-795.
83. 2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412-4417.
84. Ishizaka Y, Tanaka M, Kitamura K, et al: Adrenomedullin stimulates cyclic AMP formation in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1994; 200: 642-646.
85. Shepro D, Morel NM: Pericyte physiology. FASEB J 1993; 7: 1031-1038.
86. Herman IM, D'Amore PA: Microvascular pericytes contain muscle and nonmuscle actins. J Cell Biol 1985; 101: 43-52.
87. Allt G, Lawrenson JG: Pericytes: cell biology and pathology. Cells Tissues Organs 2001; 169: 1-11.
88. Watanabe K, Takayasu M, Noda A, et al: Adrenomedullin reduces ischemic brain injury after transient middle cerebral artery occlusion in rats. Acta Neurochir (Wien) 2001; 143: 1157-1161.
89. Holland JP, Sydserff SG, Taylor WA, Bell BA: Calcitonin gene-related peptide reduces brain injury in a rat model of focal cerebral ischemia. Stroke 1994; 25: 2055-2058.
90. Saito T, Itoh H, Chun TH, et al: Coordinate regulation of endothelin and adrenomedullin secretion by oxidative stress in endothelial cells. Am J Physiol Heart Circ Physiol 2001; 281: H1364-1371.
91. Nakayama M, Takahashi K, Murakami O, Shirato K, Shibahara S: Induction of adrenomedullin by hypoxia in cultured human coronary artery endothelial cells. Peptides 1999; 20: 769-772.
92. Caro J: Hypoxia regulation of gene transcription. High Alt Med Biol 2001; 2: 145-154.
93. Garayoa M, Martinez A, Lee S, et al: Hypoxia-inducible factor-1 (HIF-1) up-regulates adrenomedullin expression in human tumor cell lines during oxygen deprivation: a possible promotion mechanism of carcinogenesis. Mol Endocrinol 2000; 14: 848-862.
94. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000; 14: 1983-1991.
95. Nishikimi T, Mori Y, Kobayashi N, et al: Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats. Hypertension 2002; 39: 1077-1082.
96. Nagaya N, Goto Y, Satoh T, et al: Intravenous adrenomedullin in myocardial function and energy metabolism in patients after myocardial infarction. J Cardiovasc Pharmacol 2002; 39: 754-760.
97. Shindo T, Kurihara H, Maemura K, et al: Hypotension and resistance to lipopolysaccharide-induced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101: 2309-2316.
98. Kikumoto K, Kubo A, Hayashi Y, et al: Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage. Anesth Analg 1998; 87: 859-863.
99. Kassell NF, Sasaki T, Colohan AR, Nazar G: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 1985; 16: 562-572.
100. Wijdicks EF, Heublein DM, Burnett JC Jr: Increase and uncoupling of adrenomedullin from the natriuretic peptide system in aneurysmal subarachnoid hemorrhage. J Neurosurg 2001; 94: 252-256.
101. Benedict CR, Loach AB: Sympathetic nervous system activity in patients with subarachnoid hemorrhage. Stroke 1978; 9: 237-244.
102. Ishimitsu T, Nishikimi T, Saito Y, et al: Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158-2161.
103. Xi G, Hua Y, Bhasin RR, Ennis SR, Keep RF, Hoff JT: Mechanisms of edema formation after intracerebral hemorrhage: effects of extravasated red blood cells on blood flow and blood-brain barrier integrity. Stroke 2001; 32: 2932-2938.
104. Germano A, d'Avella D, Imperatore C, Caruso G, Tomasello F: Time-course of blood-brain barrier permeability changes after experimental subarachnoid haemorrhage. Acta Neurochir (Wien) 2000; 142: 575-580.
105. Gallai V, Sarchielli P, Floridi A, et al: Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia 1995; 15: 384-390.
106. Fischer HP, Eich W, Russell IJ: A possible role for saliva as a diagnostic fluid in patients with chronic pain. Semin Arthritis Rheum 1998; 27: 348-359.
107. Ashina M, Bendtsen L, Jensen R, Schifter S, Olesen J: Evidence for increased plasma levels of calcitonin gene-related peptide in migraine outside of attacks. Pain 2000; 86: 133-138.
108. May A, Goadsby PJ: The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab 1999; 19: 115-127.
109. Hong KW, Yoo SE, Yu SS, Lee JY, Rhim BY: Pharmacological coupling and functional role for CGRP receptors in the vasodilation of rat pial arterioles. Am J Physiol 1996; 270: H317-323.
110. Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Takeda H, Yokoyama M: Calcitonin gene-related peptide (CGRP) and the regulation of cerebral parenchymal vessels. Brain Res 1995; 698: 95-99.
111. McCulloch J, Uddman R, Kingman TA, Edvinsson L: Calcitonin gene-related peptide: functional role in cerebrovascular regulation. Proc Natl Acad Sci U S A 1986; 83: 5731-5735.
112. Akiyama S, Kawasaki H, Shimogai A, Kurosaki Y: Adrenomedullin inhibits neurotransmission of calcitonin gene-related peptide (CGRP)-containing vasodilator nerves in rat mesenteric resistance arteries. Peptides 2001; 22: 1887-1893.
113. Minamino N, Kangawa K, Matsuo H: Adrenomedullin: a new peptidergic regulator of the vascular function. Clin Hemorheol Microcirc 2000; 23: 95-102.
114. Iwasaki H, Eguchi S, Shichiri M, Marumo F, Hirata Y: Adrenomedullin as a novel growth-promoting factor for cultured vascular smooth muscle cells: role of tyrosine kinase-mediated mitogen-activated protein kinase activation. Endocrinology 1998; 139: 3432-3441.
115. Kato H, Shichiri M, Marumo F, Hirata Y: Adrenomedullin as an autocrine/paracrine apoptosis survival factor for rat endothelial cells. Endocrinology 1997; 138: 2615-2620.
116. Shichiri M, Kato H, Doi M, Marumo F, Hirata Y: Induction of max by adrenomedullin and calcitonin gene-related peptide antagonizes endothelial apoptosis. Mol Endocrinol 1999; 13: 1353-1363.
117. Sata M, Kakoki M, Nagata D, et al: Adrenomedullin and nitric oxide inhibit human endothelial cell apoptosis via a cyclic GMP-independent mechanism. Hypertension 2000; 36: 83-88.
118. Zhao Y, Hague S, Manek S, Zhang L, Bicknell R, Rees MC: PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogene 1998; 16: 409-415.
119. Sugano T, Tsuji H, Masuda H, et al: Adrenomedullin inhibits angiotensin II-induced expression of tissue factor and plasminogen activator inhibitor-1 in cultured rat aortic endothelial cells. Arterioscler Thromb Vasc Biol 2001; 21: 1078-1083.
120. Caron KM, Smithies O: Multiple roles of adrenomedullin revealed by animal models. Microsc Res Tech 2002; 57: 55-59.
121. Kohno M, Hanehira T, Kano H, et al: Plasma adrenomedullin concentrations in essential hypertension. Hypertension 1996; 27: 102-107.
122. Kato J, Kobayashi K, Etoh T, et al: Plasma adrenomedullin concentration in patients with heart failure. J Clin Endocrinol Metab 1996; 81: 180-183.
123. Katsuki A, Sumida Y, Gabazza EC, et al: Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus. Eur J Endocrinol 2002; 147: 71-75.
124. Ruzicska E, Toth M, Tulassay Z, Somogyi A: Adrenomedullin and diabetes mellitus. Diabetes Metab Res Rev 2001; 17: 321-329.
125. Hirata Y, Mitaka C, Sato K, et al: Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996; 81: 1449-1453.
126. Di Iorio R, Marinoni E, Letizia C, Villaccio B, Alberini A, Cosmi EV: Adrenomedullin production is increased in normal human pregnancy. Eur J Endocrinol 1999; 140: 201-206.
127. Doods H, Hallermayer G, Wu D, et al: Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. Br J Pharmacol 2000; 129: 420-423.